HIGH-QUALITY COMPLIANT e COA DATA CAPTURED ACROSS GROUP OF ONCOLOGY STUDIES
HIGH-QUALITY COMPLIANT e COA DATA CAPTURED ACROSS GROUP OF ONCOLOGY STUDIES
2 PagesSITUATION A leading pharmaceutical company required an eCOA vendor to support a group of oncology studies in multiple oncology indications. The eCOA solution needed to be customized for each study to enable sites to easily enroll the right patients, capture site-based Quality of Life (QoL) assessments on tablets and deliver engaging training content. This study program involved 200 sites across 30 countries with approximately 2,500 patients across several indications, including: > Solid tumors > Prostate cancer > Hodgkin's Lymphoma > Bladder cancer > Lung Cancer QoL assessments were collected from patients at each investigative site, including EQ-5D, QLQ-C30 and FACT-P. SUMMARY > eCOA solution to capture site data in multi-indication oncology studies > Provisioned tablets
